Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of BIBR 1048 MS (Dabigatran) in Healthy Japanese and Caucasian Subjects
NCT02170844Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jun 2004
- Primary completion
- Aug 2004
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of dabigatran in thromboembolism (4 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Change from baseline in blood pressure (BP), Change from baseline in pulse rate (PR) and 7 more. Started Jun 2004; status: completed.
02
Drugs
dabigatran
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT02170844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02170844.